178 reports of this reaction
4.3% of all RILPIVIRINE HYDROCHLORIDE reports
#2 most reported adverse reaction
PAIN is the #2 most commonly reported adverse reaction for RILPIVIRINE HYDROCHLORIDE, manufactured by Janssen Products, LP. There are 178 FDA adverse event reports linking RILPIVIRINE HYDROCHLORIDE to PAIN. This represents approximately 4.3% of all 4,147 adverse event reports for this drug.
Patients taking RILPIVIRINE HYDROCHLORIDE who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among RILPIVIRINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for RILPIVIRINE HYDROCHLORIDE:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 178 FDA reports for RILPIVIRINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 4.3% of all adverse event reports for RILPIVIRINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience pain while taking RILPIVIRINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.